Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-25 Sale |
2025-03-26 4:30 pm |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
2,631 | $6.6 | $17,365 | 221,373 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-21 4:00 pm |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
16,496 | $2.9633 | $48,883 | 220,315 (Direct) |
View |
| 2024-08-14 Sale |
2024-08-16 4:47 pm |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
31,505 | $2.7687 | $87,228 | 319,868 (Direct) |
View |
| 2024-05-29 Sale |
2024-05-31 4:07 pm |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
53,368 | $2.5504 | $136,110 | 214,433 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-25 Exercise |
2025-03-26 4:30 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
2,631 | $1.43 | 221,373 (Direct) |
View |
| 2025-03-25 Exercise |
2025-03-26 4:30 pm |
N/A 2025-05-14 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
2,631 | $0 | 221,373 (Direct) |
View |
| 2025-03-10 Option Award |
2025-03-12 4:00 pm |
2025-03-10 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
32,000 | $0 | 32,000 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 4:00 pm |
N/A 2035-02-17 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
116,000 | $0 | 116,000 (Direct) |
View |
| 2024-08-19 Exercise |
2024-08-21 4:00 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
16,496 | $1.43 | 220,315 (Direct) |
View |
| 2024-08-19 Exercise |
2024-08-21 4:00 pm |
N/A 2024-11-24 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
16,496 | $0 | 220,315 (Direct) |
View |
| 2024-08-14 Exercise |
2024-08-16 4:47 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
31,505 | $1.43 | 319,868 (Direct) |
View |
| 2024-08-14 Exercise |
2024-08-16 4:47 pm |
N/A 2024-11-24 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
31,505 | $0 | 319,868 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 4:07 pm |
N/A 2024-07-01 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
59,354 | $0 | 214,433 (Direct) |
View |
| 2024-05-29 Exercise |
2024-05-31 4:07 pm |
N/A N/A |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
59,354 | $2.19 | 214,433 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 4:42 pm |
N/A 2034-02-14 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-16 5:23 pm |
N/A 2033-02-15 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Scientific Officer |
187,500 | $0 | 187,500 (Direct) |
View |
| 2022-09-19 Option Award |
2022-09-19 4:30 pm |
2022-09-19 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer |
7,500 | $0 | 37,500 (Direct) |
View |
| 2022-06-29 Option Award |
2022-07-01 4:51 pm |
2022-06-29 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-02-11 Option Award(A) |
2022-07-01 4:44 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:01 pm |
N/A 2032-02-10 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 4:15 pm |
N/A 2031-02-16 |
Trevi Therapeutics Inc. | TRVI | SCIASCIA THOMAS Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |